Cite
HARVARD Citation
Zhang, L. et al. (2016). The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial. Redox report. pp. 14-23. [Online].